chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd Moderna shot in May 2022 led to armpit rash that lasted a day or so. Aches, pains, and fatigue were issues as well.   3rd Moderna shot (booster) on 12/5/21. Only symptom was arm soreness that lasted a couple days. Then on the morning of 12/16/21, I broke out into hives that have not gone away entirely (writing on 12/21/21). Seriously itchy/burning hives that migrate around the body?started on chest, then moved to neck, head, arms, hands and feet, stomach, legs, hips. They continue to migrate. When I woke up on 12/18/21 with swollen eyes and a feeling that I had something stuck in my throat, I went to urgent care. They gave me a Benadryl IV and a course of prednisone (steroids), as well as over the counter Benadryl, Zertyc, and Benadryl cream. These have helped only intermittently, and I am still getting bouts of hives at least twice a day.
Patient complained of extreme pain at injection site during and following injection of Shingrix in left arm. She warned ahead of time that last time she got the shingrix in her left arm, it hit a nerve and it radiated all the way down her arm to her fingertips for atleast 24 hours so to be careful.  Immediately upon inserting needle she jerked arm back and said it hurt. The innoculation was finished and upon taking out the needle, the area within 1 to 2 inches around the site was extremely tender.  It was placed about 2.5 to 3 inch directly below the shoulder joint . She said it did not radiate down her arm this time but she had trouble lifting her arm even.  (it was the arm as the first shingrix)  She also received a flu shot in her right arm  just before the shingrix, and it was fine.
Back Pain; Urination issues.; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back Pain) and MICTURITION DISORDER (Urination issues.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back Pain) and MICTURITION DISORDER (Urination issues.). At the time of the report, BACK PAIN (Back Pain) and MICTURITION DISORDER (Urination issues.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment medication was not provided.
massive amount of congestion; This case was reported by a consumer and described the occurrence of respiratory tract congestion in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th December 2020 13:00, the patient received Shingrix. On 6th December 2020, less than a day after receiving Shingrix, the patient experienced respiratory tract congestion. On an unknown date, the outcome of the respiratory tract congestion was unknown.   It was unknown if the reporter considered the respiratory tract congestion to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per vaccine indication. The reporter's friend got a shingles shot and had a massive amount of congestion but no fever, also asked if there could be a connection. The congestion was conservatively coded as nasal congestion.
Heart palpitations that turned into sinus tachycardia lasting for around 6 hours until intervention. Heart rate peaked around 180. Rapid heart rate was likely a response to a high fever of 103 degrees F.
pt expired of septic shock 2 days post vax;this report being filed as a precaution;vaccine not believed to result in septic shock;
Fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and MYALGIA (Body aches) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and MYALGIA (Body aches). At the time of the report, PYREXIA (Fever) and MYALGIA (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Low Magnesium levels 2/24 Mag 1.5, 3/4 received 4gm Mag Sulfate, 3/8 Mag 1.6 (obtained from Hospital.  Death within 30 days of vaccination
Headache, Fever, 100.1 FEVER, CHILLS. Narrative:
This spontaneous report was received from a Licensed Vocational Nurse (LVN), referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapy, drug and allergy history were not provided. On an unknown date, the patient was vaccinated with an improperly stored dose of ROTATEQ (strength, dose number, dose and frequency were not reported) orally, lot number M041184, expiration date 31-MAY-2018, for prophylaxis. On an unspecified date, the vaccine was exposure to a temperature excursion; the data logger registered a temperature of 70.7° Fahrenheit (F) during a time frame of 2 hours and 36 minutes. There was not previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1710USA000593: US-009507513-1710USA011267: US-009507513-1710USA011268: US-009507513-1710USA011269: US-009507513-1710USA011270: US-009507513-1710USA011271: US-009507513-1710USA011273: US-009507513-1710USA011274: US-009507513-1710USA011275.
Mother presented with female child for age 11 imms.  Child received HPV, Tdap, and MCV4.  Tolerated vaccinations well in nurse office, but when she was in the waiting room preparing to leave, it was reported that she experienced an episode of syncope, fell backwards, and hit the back of her head to the floor.
Patient felt lightheaded and dizzy. She was seen to by a nurse on staff and by Dr. After laying down for a while, patient felt better and wished to return to work. When contacted to following day, she said that she was feeling better, but felt a bit foggy the day before.
PRODUCT COMPLIANT; ADMINISTRATION OF VACCINE FROM VIAL OPEN FOR 17 HOURS; 6 DOSES WITHDRAWN PER VIAL; This spontaneous report received from a health care professional concerned a 38 year old of unspecified sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: 25-MAY-2021) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced 6 doses withdrawn per vial. On 27-MAR-2021, the subject experienced administration of vaccine from open for 17 hours. On an unspecified date, the subject experienced product compliant. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of vaccine from open for 17 hours, 6 doses withdrawn per vial and product compliant was not reported. This report was non-serious. This case is a duplicate of 20210354363. This case, from the same reporter is linked to 20210354152. This case is associated with PQC number 90000174514.
had a little soreness on the arm; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "had a little soreness on the arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
weakness; headache; flu-like symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose), administration date: 11Mar2021, for Covid-19 Immunisation, reaction(s): "weakness", "sore arm". The following information was reported: ASTHENIA (non-serious), outcome "unknown", described as "weakness"; HEADACHE (non-serious), outcome "unknown", described as "headache"; INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "flu-like symptoms".  Additional Information: Caller (Name withheld) reports symptoms experienced by her and her husband while taking the vaccine. 1st dose taken on 11Mar and 2nd dose on 01Apr. Caller has experienced weakness sore arm after the 1st dose and weakness, headache and flu-like symptoms after the 2nd dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a licensed practical nurse regarding unspecified patients of unknown age and gender. The patients' pertinent medical histories, drug reactions or allergies and concomitant therapies were not reported. On unspecified dates, the patients were vaccinated with improperly stored ROTATEQ Vial, lot # M019707 with expiry date 25-OCT-2017 (dosing details unknown). The administered dose experienced a temperature excursion of 60.1 Fahrenheit (F) for 14 hours and 15 minutes, 47.5 Fahrenheit (F) for 30 minutes, 47.3 Fahrenheit (F) for 30 minutes, 50.7 Fahrenheit (F) for 30 minutes and 32.7 Fahrenheit (F) for 2 hours and 15 minutes. There was no previous temperature excursion. The call was because of a data logger. No symptoms were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
This initial non-serious spontaneous case, received on 09-Oct-2017, reported by other health professional and concerns a female patient of unknown age. Patient's medical history was not reported. On 05-Oct-2017, breast feeding patient received FLUCELVAX QIV (dose: 0.5 ml, expiry date, batch number, route of administration, anatomical location, trade name, manufacturer: not reported). The outcome of the event was not reported.
strong odor in my nose; metallic taste; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2) (Lot number: ER8737) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LOSARTAN; HYDROCHLOROTHIAZIDE; VITAMIN D3. The following information was reported: PAROSMIA (non-serious), outcome "recovering", described as "strong odor in my nose"; DYSGEUSIA (non-serious), outcome "recovering", described as "metallic taste". Therapeutic measures were not taken as a result of parosmia, dysgeusia.  Additional information: Patient had no covid prior vaccination.The patient had not been tested post vaccination. Device timestamp: 04May2021.The patient did not receive any other vaccines in 4 weeks.  No follow-up attempts are possible. No further information is expected.
Information has been received from a health professional concerning a 15 month old male with no known medical history who on 1/9/04 was vaccinated SC in the left thigh with a first dose of varicella virus vaccine live (lot # 646535/0575N). There was no concomitant medication. On 5/4/04 the patient developed full blown chicken pox. On 5/6/04, the patient was seen at the physicians office with 100 pox-like lesions and no fever or malaise was noted. At the time of the report, the patient had not recovered. There was no laboratory studies performed and no treatment was required. A product quality complaint was not involved. Follow up information from the registered nurse indicated that the patient was seen in the office on 5/6/04 with a classic varicella rash from head to toe which started on 5/5/04. The patient was afebrile. Symptomatic relief was noted. On 5/10/04, the patient recovered. No further information is available.
After receiving MMR #1 that night he developed severe hives all over his body and face but it  disappeared in the morning . He could not sleep and took Benadryl
pt rcvd vax; 4 hrs later pt devel pain & a large swelling in injection arm;
Our daughter had a seizure, while walking in the hallway, at school.  This was her second seizure.  Her first seizure was in December 2021.  Ironically, This seizure occurred three days after receiving her second Co-vid 19 vaccine.  The seizure was 6 mins in duration.Our daughter has a rare brain tumor called Craniopharyngioma.  Due to the tumor, does not have a functional pituitary gland.  She replaces her hormones orally each day.
I started having really bad itching, pain and redness at (and around) the injection site the day after I got the vaccine. I also have extreme fatigue at times and body soreness, but the itching is what is most concerning at this point. I didn't have reactions as bad as this to the first dose.
Day after vaccine Had low grade fever of 99.8, pain in leg and right lung. Rested and pain didn?t elevate with rest and Tylenol. Shortness of breath became worse went to the ER. Pain in lung causing shortness of breath. Leg pain. Labs, ECG, venous Doppler and chest X-ray. All returned in normal limits. Diagnosis: Acute chest pain. vaccine reaction, initial encounter. Still having shortness of breath and pain in right lung. Will follow up with primary care doctor
Pt recvd Hep B vax on 18MAY92 & w/in 45 mins of inject pt devel lt arm pain that radiated into shoulder & into lt chest; SOB, nausea;
Three hours after receiving the pneumonia shot in the left deltoid, developed severe painin upper arm to elbow to under arm pit. In 4-5 hours after injection, developed swelling, redness, hotness and "hardness" of upper arm. Also, chills and nausea. Lasted 2 full days then symptoms gradually decreased 3 or 4 days.
28hr p/vax pt started getting red bumps on skin & by the next day was covered from head to toe in bumps;MD states pt had hives-no fever;
30 minutes, post vax, tetany noted with severe pain, lasting 12 hours; intermittent tetany remains with pain left deltoid, radiates to hand and at times to left clavicle, up left side of neck. Condition remains sporadic to this date.
I had very mild symptoms such as a sore throat and a cough. I also did isolation.
Patient reported feeling nauseous after vaccine, Patient was asked to put her head on her knees for a couple of minutes which she reported helped.  After further investigation, patient reported she didn't have much to eat today.
Itchiness and swelling at the injection site; Itchiness and swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness and swelling at the injection site) and VACCINATION SITE SWELLING (Itchiness and swelling at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRINE) and ATORVASTATIN for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness and swelling at the injection site) and VACCINATION SITE SWELLING (Itchiness and swelling at the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchiness and swelling at the injection site) and VACCINATION SITE SWELLING (Itchiness and swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included dabbed alcohol swab to ease itching.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
61 yof c/o L upper lip itching s/p 15 min observation of Pfizer COVID19 vaccine #2   4:19 PM: 15 min observation ended   Pt in no resp distress Pt speaking in clear and complete sentences Pt A&O x 4  Pt here with husband States Pfizer #1 vaccine she only felt really hot during observation period of 15 min Pt reports Hx of HTN Pt reports taking atenolol 25 mg 1 tab daily (has not taken today), tums Allergies: antesthesia   (+)  Itching   Denies CP, SOB, difficulty breathing Denies sensation of throat closing or throat tightness, high-pitched sound while breathing (stridor), hoarseness, SOB, wheezing cough, trouble swallowing, drooling, nasal congestion, sneezing, runny nose Denies abd pain, cramps, nausea, vomiting, diarrhea Denies dizziness, fainting, tachycardia, hypotension, pulse difficult to find or "weak", bluish discoloration, pallor, flushing Denies generalized hives, widespread redness, eye redness, swelling of lips/tongue/throat/face/or extremities Denies agitation, convulsions, acute change in mental status, sense of impending doom Denies sudden inc in secretions from eyes/nose/or mouth, urinary incontinence   4:24 PM L upper lip 1/10 itch; mild redness Middle of forehead 1/10 itch; mild redness   4:32 PM: L upper lip and middle of forehead no longer itchy or red   4:33 PM: Tip of tongue tingly 2/10   Consulted with NP whom provided verbal order for Benadryl 50 mg PO    4:48 PM: Benadryl 25 mg PO x 2 capsules adm to pt NDC: 0904-5306-24 LOT: 205386 EXP: 05/23   5:07 PM: 0/10 tongue tingling Denies any SXs or concerns VS WNL Total observation 4:04 PM-5:07 PM   Offered pt care f/u appt with PCP; pt states she will call back to schedule f/u Home care instructions and ER precautions provided Instructed pt to advise if SXs worsen or new SXs arise Pt verbalized understanding and had no further questions Pt left clinic in stable and ambulatory condition with husband
Two weeks after vaccine my arm turned red, swollen up, whelps and itching and raised area at the injection site but no pain.
Chills; Tender arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tender arm) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 044B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure high and Hypothyroidism.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021 at 12:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TENDERNESS (Tender arm). On 13-May-2021, the patient experienced CHILLS (Chills). On 13-May-2021, CHILLS (Chills) had resolved. At the time of the report, TENDERNESS (Tender arm) outcome was unknown.            Concomitant product use include  medications for  diabetes, high blood pressure  and hypothyroid.   At about 3-4am on 13May2021, patient began feeling chills. When she woke up that morning at 8am, they were gone. No medications taken to treat symptoms.  No treatment medications were reported.
had red & swollen arm, swollen gland under lt arm, t102 for 24 hrs starting 19OCT94; came back to work on 10-20 & lt work for 2 hrs-temp back;
SkinRash Narrative: Mild rash at injection site night of injection, resolved by morning
hallucinations; coughing; trouble sleeping; headache; This spontaneous case was reported by a consumer and describes the occurrence of HALLUCINATION (hallucinations) in an 81-year-old female patient who received mRNA-1273 (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history reported.     On 28-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced HALLUCINATION (hallucinations) (seriousness criterion medically significant), COUGH (coughing), INSOMNIA (trouble sleeping) and HEADACHE (headache). At the time of the report, HALLUCINATION (hallucinations), COUGH (coughing), INSOMNIA (trouble sleeping) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.       Concomitant medication was not reported.  Treatment information was not provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 31-JAN-2012, the patient was administered with a dose of VARIVAX (Merck) (Lot # 0869AA, expiry date unknown) (Route, dosing regimen and frequency unknown) which was exposed to a temperature excursion of up to -3 degrees Centigrade. No adverse events were reported. No product quality issue was reported. This is one of the many reports received from the same source. Additional information has been requested.
The patient was admitted to the hospital with chest pain, abnormal ECG, and elevated troponin.  He underwent urgent cardiac catheterization, which showed normal coronary arteries.  His left ventricular ejection fraction was reduced.  His clinical picture was consistent with myocarditis.
Later that night I developed a ringing in my left ear and it was painful. I reached out to my PCP who scheduled an ENT specialist appt. An ear examination and Audiology test was done and as a result of the test it has been discovered that I have since lost some hearing in what is called my high frequency  range only in the left ear. ENT complete the routine exam and looked with a camera up my nostrils. I never associated it with the vaccine until the ENT was asking various questions and that's when I realized that the ringing started the same day I got the 1st injection and just had carried over still to date 6 months later. The ENT advised to wait awhile so I have an appointment set for late Nov to see if it will heal itself by then and if not other treatments will be accessed then. The soreness went away after about 1 month and the volume of the ringing varies throughout the day, but its still there.
Woke up on 3/11/21 very dizzy and felt nauseous all day.  Arm pain was severe - some numbness in face and left hand.  Woke up on 3/12/21 feeling much better but by noon - started feeling dizzy and nauseous again and that lasted the rest of the day.
Patient came in after 1 month getting the vaccination and explains that she has been having occasional radiating pain on her arm. She also goes on to say that the pain might be due to Arthritis or related to work due to tension/stress from lifting. I advise her to see her doctor and let me know the outcome.